KLOW vs GLOW: Comparing Two Multi-Peptide Research Blends

July 10, 2026

The short answer: KLOW and GLOW share the same three-peptide backbone of GHK-Cu, BPC-157 and TB-500, and the single difference is that KLOW adds a fourth peptide, KPV. Both are multi-peptide research blends supplied as lyophilised material for research use only, not for human or veterinary use.

Composition at a glance

Constituent	KLOW	GLOW
BPC-157	✓	✓
TB-500	✓	✓
GHK-Cu	✓	✓
KPV	✓	–
Number of peptides	Four	Three
Total vial size	80 mg	70 mg
Intended use	Research use only	Research use only

In other words, the KLOW peptide blend is the GLOW peptide blend plus KPV. The larger 80 mg KLOW vial reflects that additional constituent, while GLOW concentrates the shared trio into a 70 mg presentation.

The shared trio: BPC-157, TB-500, GHK-Cu

Both blends are built on three peptides that are frequently studied together in tissue-repair and regenerative research models. Describing what each is investigated for helps clarify why the two products overlap so closely.

BPC-157 is a synthetic pentadecapeptide fragment studied for its role in angiogenesis and cell-migration pathways. In preclinical and in-vitro settings, investigators have examined its association with vascular endothelial growth factor (VEGF) signalling and with connective-tissue and gastrointestinal repair models.
TB-500 is a synthetic fragment related to thymosin beta-4 and is investigated in relation to actin regulation and cell motility. Research contexts include cell migration, angiogenesis and the modulation of inflammatory pathways in experimental repair models.
GHK-Cu is a copper-binding tripeptide (glycyl-L-histidyl-L-lysine complexed with copper) studied for its role in extracellular-matrix remodelling. It is of research interest for pathways linked to collagen and elastin synthesis, copper transport and the regulation of matrix metalloproteinases.

Because these three peptides are often combined in the same experimental protocols, the shared trio is available both as the standalone GHK-Cu peptide and within the BPC-157/TB-500 Mix, allowing researchers to isolate individual variables when a study calls for it.

What KPV adds in KLOW

The distinguishing feature of KLOW is KPV, a short tripeptide (lysine-proline-valine) derived from the C-terminal region of alpha-melanocyte-stimulating hormone (α-MSH). KPV is studied primarily in the context of inflammatory-signalling pathways rather than the matrix-remodelling and angiogenic pathways emphasised by the shared trio.

In in-vitro and preclinical research, KPV has been investigated for its association with the modulation of pro-inflammatory mediators, including pathways linked to NF-κB signalling and cytokine expression. Because it is a very short sequence, it is also of methodological interest to researchers examining how compact peptides behave alongside larger fragments such as BPC-157 and TB-500 within the same preparation.

This gives KLOW a broader mechanistic footprint on paper: the GHK-Cu, BPC-157 and TB-500 backbone contributes repair- and matrix-associated research pathways, while the added KPV extends the blend into inflammation-focused research questions. Where GLOW keeps the design centred on the shared trio, KLOW layers an additional signalling axis on top of it. As with every constituent, this description characterises scientific interest only and is not a therapeutic claim, and neither blend is intended for human or veterinary use.

Research uses and how to choose

Choosing between the two blends depends on the pathways your study is designed to probe. If your research question centres on the combined angiogenic, cell-migration and matrix-remodelling pathways of the core trio, the GLOW peptide blend provides that three-peptide combination in a single lyophilised vial.

If your protocol also needs to account for an inflammation-associated variable, the KLOW peptide blend adds KPV to the same backbone, letting you examine the trio and the anti-inflammatory tripeptide within one preparation. Some laboratories acquire both and use the presence or absence of KPV as an experimental variable, isolating its contribution against an otherwise identical three-peptide reference. For work that requires separating a single constituent, the standalone TB-500 and GHK-Cu products, together with the BPC-157/TB-500 Mix, complete the set of building blocks.

Formats, purity and COA

Both blends are supplied as lyophilised material so they can be reconstituted to a concentration appropriate to your study design. Each constituent is characterised to confirm identity and purity, and every batch is analysed by high-performance liquid chromatography (HPLC).

Each batch ships with a Certificate of Analysis (COA), and our full methodology is set out on the Quality Testing page. Because multi-peptide blends combine several constituents in one vial, this batch-level documentation is especially useful: it lets you record the identity and purity data for your reference material alongside your experimental results, which supports reproducibility across a comparative KLOW-versus-GLOW protocol.

Frequently asked questions

What is the difference between KLOW and GLOW?

Both blends share the same three peptides — GHK-Cu, BPC-157 and TB-500. The only difference is that KLOW adds a fourth peptide, KPV, and is presented as an 80 mg vial, whereas GLOW is the three-peptide trio in a 70 mg vial.

What is KPV?

KPV is a short tripeptide (lysine-proline-valine) derived from alpha-melanocyte-stimulating hormone. It is studied for its association with inflammatory-signalling pathways and is the constituent that distinguishes KLOW from GLOW.

Which blend has more peptides?

KLOW has more peptides. It is a four-peptide blend (BPC-157, TB-500, GHK-Cu and KPV), while GLOW is a three-peptide blend (GHK-Cu, BPC-157 and TB-500).

Do KLOW and GLOW come with a COA?

Yes. Every batch of both blends ships with a Certificate of Analysis, and our HPLC-based testing approach is outlined on the Quality Testing page.

Compare the two side by side and source HPLC-tested material with per-batch documentation: explore the KLOW four-peptide blend and the GLOW three-peptide blend for your next study.